Datavault AI Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Datavault AI Inc. (DVLT) on August 4, 2025. The filing details a registered direct offering of senior secured convertible notes, the execution of exchange agreements regarding existing warrants, and the amendment of prior notes. The company is incorporated in Delaware and trades on The Nasdaq Capital Market.
Key Financial Metrics and Transaction Details
- Debt Issuance: The Company entered into a Securities Purchase Agreement to issue senior secured convertible notes with an aggregate principal amount of $13,333,332 ($6,666,666 Initial Notes and $6,666,666 Additional Notes).
- Proceeds: The aggregate purchase price for the notes is $12,000,000 ($6,000,000 for Initial Notes and $6,000,000 for Additional Notes).
- Conversion Terms: Notes are convertible at an initial price of $1.00 per share. An alternate conversion price is available, calculated as the greater of a floor price of $0.1019 or 80% of the lowest 20-day VWAP.
- Warrant Exchange: Holders agreed to exchange approximately 31 million shares of Common Stock purchase warrants for an equivalent number of shares of Common Stock.
- Stockholder Approval: Holders of 50,365,422 shares (approximately 52% of voting power) executed a written consent to approve the issuance of up to 130,847,236 shares of Common Stock related to the notes and exchanges.
Material Changes and Amendments
The filing discloses an amendment to senior secured convertible notes issued on April 3, 2025, and May 21, 2025 (Prior Notes). The amendment revises the "Alternate Conversion" price calculation for these prior notes. The new formula sets the price at the greater of the floor price or 80% of the lowest VWAP in the 20 trading days prior to conversion, changing from the previous 90% of the lowest VWAP in the 10 trading days prior.
Outlook, Risks, and Contingencies
- Closing Conditions: The Initial Closing is subject to customary conditions. The Additional Closing is contingent on the satisfaction of additional conditions and will occur on or after the date that is 20 calendar days after the mailing of a definitive information statement on Schedule 14C.
- Regulatory Timing: None of the actions approved in the Written Consent may become effective earlier than 20 calendar days following the mailing of the Information Statement to stockholders.
- Dilution Risk: The transaction involves the potential issuance of a significant number of shares (up to 130,847,236) upon conversion or exchange, subject to Nasdaq Listing Rule 5635(d) compliance.
Investor Verification Checklist
- Verify the final closing date and confirmation of the $12,000,000 proceeds receipt.
- Monitor the filing and mailing date of the Schedule 14C Information Statement to determine the effective date of the stockholder consent.
- Review the definitive terms of the Note Amendment for the Prior Notes to confirm the new conversion pricing mechanics.
- Assess the impact of the potential issuance of 130,847,236 shares on existing shareholder dilution.
- Confirm the status of the warrant exchange and the number of shares actually issued upon completion.